250+ investors that invest in your industry and stage
Get 250+ investors tailored to your startup
  • Invest in your industry and stage
  • Emails & contact info included
  • Excel and CSV export
  • Automatically
Trusted by 3,000+ startups

Top 50 Biotech VC (Venture Capital) Funds in Italy in April 2025

A list of 50 VC (Venture Capital) funds that invest in Biotech startups based in Italy. We rank investors based on the number of investments they made in Biotech companies from Italy. We update this investor list every month.

Top 50 Biotech VC (Venture Capital) Funds in Italy in April 2025

Investor Biotech Italy investments
Sofinnova Partners 11
Italian Angels for Growth 9
Indaco Venture Partners 7
Vertis 7
CDP Venture Capital 7
LIFTT 6
Principia SGR 6
Innogest Capital 5
A11 Venture 4
Green Arrow Capital 4
Invitalia Ventures 3
Atlante Ventures 3
Progress Tech Transfer Fund 3
INGENIUM Emilia Romagna 3
Club degli Investitori 3
Claris Ventures 3
Eureka Venture 3
StartUp Health 2
European Circular Bioeconomy Fund 2
Panakes Partners 2
3LB Seed Capital Srl 2
Italian Angels for Biotech 2
Lazio Innova 2
Intesa Sanpaolo 2
UniCredit 2
Kering Ventures 2
3B Future Health Fund 2
European Investment Bank 2
Banco BPM 2
Spindial Group 1
MVM Life Science Partners 1
United Ventures 1
Sparta Capital 1
Cube Labs 1
Embed Capital 1
Padda Health 1
Longwood Fund 1
Forbion Capital Partners 1
FITEC 1
Crédit Agricole Italia 1
Estor 1
Angels4Women 1
Schia Ventures 1
Scientifica Venture Capital 1
Launch Tennessee 1
Lumen Ventures 1
AbbVie Biotech Ventures 1
Finalca 1
Angelini Ventures 1
a|impact 1
Find investors that fund startups like yours. Automatically.
Our algorithm will find investors that invest in your industry, stage, and geography.
Investor list
Sofinnova Partners VC Fund · Paris, Ile-de-France, France · 19 investments in the past 12 months
Sofinnova Partners is a leading European venture capital firm in life sciences, specializing in healthcare and sustainability. Based in Paris, London and Milan, the firm brings together a team of professionals from all over the world with strong scientific, medical and business expertise.
Show more
Investment focus
  • Biotechnology, Health Care, Medical
  • Series A, Series B, Series C
  • France, United States, United Kingdom
Portfolio highlights
  • Bioptimus — Our mission is to build the first universal AI foundation model for biology to fuel breakthrough discoveries and accelerate innovations in biomedicine and beyond.
  • Latent Labs — Latent Labs is making biology programmable to transform health and sustainability for the benefit of all.We are a frontier AI lab building foundational models that capture the fundamentals of biology. We empower partners with breakthrough generative AI to gain unprecedented control over molecular biology, creating new antibodies, optimizingexisting enzymes, and advancing genetic engineering.Contact us to work with us today.
  • Berry Street — Nutrition therapy by registered dietitians covered by insurance.
Italian Angels for Growth VC Fund · Milan, Lombardia, Italy · 2 investments in the past 12 months
IAG is an angel investor network that offers access to its affiliates to early-stage venture opportunities. Its members to date have deployed over 22 million Euros to support 41 startups in the series seed/series A stage in many verticals, among which: Medtech, SAAS, e-commerce, Fintech, and high tech at large. Every investment opportunityat IAG is vetted by a professional team together with expert members of the group. Once invested, the company receives the support of up to two Investment champions, who bring their expertise to the table and help them succeed.
Show more
Investment focus
  • Software, E-Commerce, Health Care
  • Seed, Angel, Series A
  • Italy, United States, United Kingdom
Portfolio highlights
  • ALKemist Bio — ALKemist Bio provides cell treatment to cancer patients.
  • Rubedo Life Sciences — Rubedo Life Sciences is the Premier Longevity Company. Rubedo discovers and develops medicines to keep you biologically young.
  • Restorative Neurotechnologies — Siamo un'azienda di dispositivi medicali certificati per la riabilitazione cognitiva ed il trattamento di disturbi cognitivi post ictus.
Indaco Venture Partners VC Fund · Milan, Lombardia, Italy · 3 investments in the past 12 months
VENTURE We invest across all sectors with specific focus on technology and digital The largest independent more About Us Portfolio [...]
Show more
Investment focus
  • Biotechnology, Health Care, Medical
  • Series A, Series B, Series C
  • Italy, Switzerland, United States
Portfolio highlights
  • D-Orbit — End-to-end services for the New Space industry, including platform engineering, launch and deployment, and decommissioning.
  • MicThera — MicThera focuses on developing microbial-derived therapeutics to provide effective treatments for prostate cancer patients, aiming to find effective solutions for medical companies.
  • Genespire — Genespire is a biotechnology company focused on the development of transformative gene therapies for patients affected by genetic diseases, particularly primary immunodeficiencies and inherited metabolic diseases.
Vertis VC Fund · Milan, Lombardia, Italy · 4 investments in the past 12 months
Vertis is a dynamic and independent investment management company authorised by Bank of Italy. It manages five closed-end funds for qualified investors by participating in research projects, spin-offs, startups and PMI and deals with the investments of the innovative Made in Italy.
Show more
Investment focus
  • Software, Health Care, Biotechnology
  • Seed, Series A, Funding Round
  • Italy, United States
Portfolio highlights
  • Radical Storage — Find your closest luggage storage and enjoy your journey until the very end!
  • Focoos AI — Focoos reshapes computer vision with ultra-efficient models that drive down costs, automate hardware integration, and ensure peak performance on any device, while promoting sustainability.
  • TimeFlow — TimeFlow is a software that acts as a B2B marketplace dedicated to the technical and managerial consulting sector.
CDP Venture Capital VC Fund · Rome, Lazio, Italy · 26 investments in the past 12 months
CDP Venture Capital Sgr - National Innovation Fund aims to make venture capital a cornerstone of the country's economic development and innovation, creating the conditions for an overall and sustainable growth of the venture capital ecosystem.
Show more
Investment focus
  • Software, Information Technology, Health Care
  • Seed, Series A, Funding Round
  • Italy, United States, Germany
Portfolio highlights
  • Mopso — Discover Mopso's anti money laundering detection system. Visit our website and try a 30 minutes free demo with one of our experts.
  • Postura Ergonomics — Postura transform workers videos into ergonomic risk assessments for manufacturing companies. Our AI delivers quick, accurate, and scalable analyses, cutting costs and compliance time. ergonomia lavoro ufficio
  • Genoa Instruments — Genoa Instruments is an innovative startup dedicated to transforming the field of biomedical and health research through advanced super-resolution optical microscopy. Our groundbreaking optical microscope uniquely integrates spatial and temporal super-resolution for structural and functional imaging in living samples with unprecedented detail. Ourmission is to make high-resolution imaging accessible to all, fostering scientific discovery and advancing healthcare research.
LIFTT VC Fund · Turin, Piemonte, Italy · 7 investments in the past 12 months
A not-only-profit operating investment company, eager to create a bridge between innovative ideas, territory and capital.
Show more
Investment focus
  • Biotechnology, Software, Information Technology
  • Seed, Funding Round, Series A
  • Italy, United Kingdom, France
Portfolio highlights
  • Mediaire — mediaire supports radiologists with AI-based tools for MRI reporting. This enables them to make a more accurate and objective assessment even faster.
  • MicroLub — MicroLub produces a fat replacement for lower-calorie plant-based diets. It is cutting-edge innovation to the next generation of protein technology, creating exclusive ingredient solutions that significantly minimize molecular friction.
  • Composite Research — CoRe Research is an start-up, aimed at the study of new product and process solutions in the field of composite materials.
Principia SGR VC Fund · Milan, Lombardia, Italy
Principia is an Italian Venture Capital firm with over Eur 80M under management. Currently Principia has two funds investing in digital start ups and expansion capital opportunities and in particular cases, we invest also in seed opportunities.
Show more
Investment focus
  • Health Care, Biotechnology, Software
  • Funding Round, Series A, Seed
  • Italy, United States, United Kingdom
Portfolio highlights
  • KLISBio — KLISBio is a medtech company currently developing a variety of regenerative medicine implantable products leveraging the power of silk fibroin to promote an endogenous repair of human soft tissues.
  • ENTEROME — We are a clinical stage biopharmaceutical company developing novel drugs to transform human health based on our unique ability to de-code molecular interactions in the gut microbiome.
  • WISE — WISE (Wiringless Implantable Stretchable Electronics) is a start-up company created in 2011 with the mission of producing the new generation of leads for neuromodulation for treatment of chronic pain and Parkinson: unbreakable, less invasive and cheaper.
Innogest Capital VC Fund · Milan, Lombardia, Italy
We are investors in companies that make the difference. We partner with hard-working entrepreneurial visionaries
Show more
Investment focus
  • Health Care, Medical, Medical Device
  • Funding Round, Series A, Series B
  • Italy, United States, Spain
Portfolio highlights
  • GreenBone Ortho — GreenBone Ortho was founded in Faenzato offer advanced and innovative solutions in the field of orthopaedics and bone regeneration, using the Rattan wood.
  • Renovacor — Renovacor is a preclinical‑stage biopharmaceutical company focused on developing transformative gene therapy‑based treatments for cardiovascular disease.Renovacor’s lead program is a recombinant adeno-associated virus (AAV)‑based gene therapy for patients suffering from dilated cardiomyopathy (DCM) due to mutations in the Bcl2‑associatedathanogene 3 (BAG3) gene.Dilated cardiomyopathy is a condition affecting over 3 million patients in the US and growing steadily. Many patients develop DCM due to ischemic heart disease. Recently subpopulations have been identified that develop DCM due to mutations in specific genes that have been shown to result in the development of DCM. One of these specific genes is the BAG3 gene. The prevalence of disease‑causing BAG3 haploinsufficiency is estimated at approximately 35,000 individuals in the United States, representing an orphan disease by FDA guidelines. It is estimated a similar number of DCM patients with BAG3 mutations exist in Europe. These patients are typically younger and progress to end-stage heart failure sooner than patients with ischemic heart disease. Currently, DCM patients with a BAG3 mutation are treated with standard of care for heart failure. Despite improvements in pharmacotherapy and care, the five‑year survival of a patient with DCM is only 50%. The development of a BAG3 gene replacement therapy for patients with DCM that carry BAG3 mutations could potentially prevent the progression of disease in this otherwise healthy population of young adults.
  • BetaGlue Technologies — BetaGlue Therapeutics is a life sciences company that delivers radiotherapy from within. Introducing Yntradose, our proprietary product.
A11 Venture VC Fund · Lucca, Toscana, Italy
A11-Venture investe nel capitale di startup innovative nei settori della robotica, automazione, meccatronica, cleantech, web e IT. Facilita la nascita e lo sviluppo di business innovativi globali per il futuro dell'economia locale. Contribuisce a costruire aziende, lavoro qualificato, brevetti, innovazione capaci di rilanciare e riportareinvestimenti e risorse sul territorio. I soci di A11 Venture credono fermamente nell’innovazione grazie a ciò è possibile crescere per linee esterne diversificando i propri investimenti, grazie ad un portafoglio di imprese, con una forte risk mitigation derivante dalla gestione professionale di tutti processi: scouting, team building, investimenti, management degli investimenti, accelerazione e disinvestimento.
Show more
Investment focus
  • Biotechnology, Medical Device, Health Care
  • Seed, Pre-Seed, Series A
  • Italy, United States
Portfolio highlights
  • Reefilla — Reefilla EV charging services: recharge your car anywhere, anytime
  • Endostart — Endostart development and manufacturing of a new generation medical devices for gastrointestinal endoscopy.
  • Neuron Guard — Neuron Guard, recognized as the best European startup in HEALTH category (Startup Europe Awards - SEUA 2017), is developing a life-saving medical device that aims to become the standard of care for Targeted Temperature Management (TTM) therapy. Every 7 seconds around the world a person suffers of Acute Brain Damage because of CardiovascularDiseases (CVD) and Traumatic Brain Injury (TBI). They are the most costly and prevalent killers in the last 15 years (15 million deaths by CVD in 2015), and the leading cause of disability (the global incidence rate of TBI is 200 per 100k people per year). WHO estimated a global expenditure of $ 330 billion in 2015, but it is going to increase sharply: $ 4 trillion in 2025 - including premature death, disability, and health care costs - just for CVD in LMICs. Temperature is a vital body parameter. It regulates all cellular functions so its management is essential for the good outcome of patients in several medical conditions such as cardiac arrest, stroke, traumatic brain injury, neuro and cardiac surgery, epilepsy, migraine and oncology. Regulating body temperature at a desired level makes all other treatments more effective. The most modern medical approach is the target temperature management, where physicians try to maintain the most favourable temperature for the patient for up to 24-36 hours, preventing excessive warming (fever) or cooling.Our device is a targeted temperature management system composed by a THERAPEUTIC COLLAR POWERED BY A SMART CONTROL UNIT (the size of a small briefcase). The collar transforms the neck into a natural heat exchanger exploiting several physiological and anatomical characteristics of the human body. It is quicker to act on brain tissue but can also function as total body temperature adjusting device if required. A disposable protective shield makes cleaning the collar after each use simple while featuring an optimal safety profile both in term of pathogens and allergens. The control unit collects all the data of the treatment and transmits them to the Emergency Response System. Our mission is to improve the safety of patients on the roadside, at home or in the workplace, and to reduce the costs of chronic care. In fact, Neuron Guard aims to be the only device that can be used in every circumstance, inside and outside the hospital, and allow the user to fully manage the temperature of the patient warming and cooling as necessary. Our vision is to have a Neuron Guard kit in every public place just like the Automatic External Defibrillator (AED) to empower bystanders to immediately react in case of emergency. Under this perspective our device becomes a connected-intelligent platform that takes care of the patient, connects the scene with the Emergency Response System transmitting vital data to improve the readiness and effectiveness of professional intervention.The device is patented in Italy, USA and China. We have made several prototypes in collaboration with Italian and English companies, such as Tecno Elettra Impianti and TWI, tested it in laboratory and published the experimental results on the NeuroCritical Care Journal. We have also conducted a GAP Analysis with another English consulting firm (CDP) and we are testing the human prototype internally. We are seeking to raise 2.5M€ to complete the pre-industrialization, with design and construction of the human device for the pilot trial, finalized the regulatory clearance and launch it into the market in 2019.
Green Arrow Capital VC Fund · Milan, Lombardia, Italy
Green Arrow Capital is an independent financial group specializing in alternative investments across Europe. They represent a one-of-a-kind platform, capable of connecting the financial system with the real economy through the management of private equity, private debt, infrastructure, and special credit situation funds as well as thematic fundssuch as microfinance and funds of funds that are currently under management. Their team has a successful track record in asset management, investment banking, industry sectors, technology startups, management consulting, renewable energy, and has government and regulatory experience. Their group is mainly composed of investment, asset management, and financial advisory companies. Their aim is to create a solid financial platform to launch and manage investment funds dedicated to alternatives and to the real economy.
Show more
Investment focus
  • Health Care, Biotechnology, Manufacturing
  • Funding Round, Seed, Series A
  • Italy, United Kingdom
Portfolio highlights
  • Cogisen — Cogisen develops artificial intelligence solutions. It offers SENCOGI, an eye-tracking software for smartphones/mobile phones. Chiara Passacantilli and Christiaan Erik Rijnders founded Cogisen in 2009. Its headquarters is in Naples in Italy.
  • Directa Plus — Directa Plus is a nanotechnology company, manufactures nanoparticles.
  • Glomeria Therapeutics — Glomeria Therapeutics researches, develops, and markets new medical devices for the treatment of serious diseases in the nephrological area. It offers DesmoPD, peritoneal dialysis connection system; SmartPD, an automated management device for peritoneal dialysis solutions to be instilled in peritoneum; and solutions for peritoneal dialysis.Andrea Zanella founded Glomeria Therapeutics in 2010. Its headquarters is in Chieti in Italy.
Invitalia Ventures VC Fund · Rome, Lazio, Italy
Invitalia Ventures SGR manages the “Italia Venture Fund I”, a 87€/Ml sized co-investment fund that invests in early stage operations in Italy. They co-invest up to a maximum of 70% in round A (€ 0.5ML - € 1.5ML) in high growth sectors. Invitalia Ventures, with its network of co-investors not only provides risk capital, but also know-how and anetwork for business development. Main LPs includes the Ministery of Economic Development, the European Investment Bank, Cisco Group, the Sardinian Banking Foundation and Metec Group.They are looking for visionary entrepreneurs who share their passion for innovation. Growth is their mission!!For more information please contact us at info@invitaliaventures.it or visit our website: www.invitaliaventures.it
Show more
Investment focus
  • Software, Medical, Health Care
  • Series A, Funding Round, Seed
  • Italy, United States, United Kingdom
Portfolio highlights
  • Ecomate — The ESG Rating platform for every company
  • BigProfiles — A deep understanding of customers let a company tailor marketing campaigns and CRM strategies, but companies have only basic data about customers (e.g. gender or age). External data sources like Social Networks, Public Registries and Socio-Demographic data contain rich information about billions of people, like job titles, levels of education,interests and habits.BigProfiles is a Customer Intelligence SAAS that leverages external information about persons to enrich customer profiling: it can profile a company's customers with previously unknown information about them. Thanks to its Identity Resolution algorithm (the result of a PHD), it identifies a person’s information scattered among external sources.Through this technology, BigProfiles provides customer base analytics and behavior predictions: using Artificial Intelligence on enriched profiles allows to predict churn, fraud and willingness to buy.
  • Codemotion — Codemotion is the ecosystem devoted to innovation, focused on developers and coding, open to all programming languages and technologies. Pioneering spirits, it scout the future to deliver a first class experience to our people. Codemotion is one of the biggest tech-conferences in Europe, with an international network of 30.000 developers and 350speakers coming from all over the world and from the most important IT realities.Codemotion draw in its main conferences, thousands of attendees eager to discuss about hottest topics: it tailor for them disruptive proposals ranging from mobile to UX, develops, cloud, big data, gamedev, security, methods, languages, web, Internet of things. Codemotion is also a startup, providing a bunch of services and activities, for personal and business customers.
Atlante Ventures VC Fund · Milano, Lombardia, Italy
Atlante Ventures is a leading Italian VC fund, operated by IMI Fondi Chiusi SGR, part of Intesa Sanpaolo Group.
Show more
Investment focus
  • Software, Biotechnology, Hardware
  • Funding Round, Seed, Series A
  • Italy, United States, Israel
Portfolio highlights
  • treet — Treet helps brands launch fully-branded recommerce sites where customers can buy & sell items from each other.
  • Newronika — Newronika restores brain and body functions with innovative technologies. We translate our deep knowledge on biosignal decoding into clinical practice, with the aim of improving treatments, health, and wellness. With our revolutionary brain devices, the patient receives the right stimulation at the right moment, thus becoming able to perform normaldaily activities and improve quality of life. Newronika is the spin-off company of two leading research institutions in Italy, the Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico Hospital and the University of Milan. ​ Newronika comprises a multidisciplinary team formed from Neuroscience research groups and involves scientists with expertise in neurophysiology, neurology, biomedical engineering, neuropsychology, bioinformatics, and biotechnologies.
  • WISE — WISE (Wiringless Implantable Stretchable Electronics) is a start-up company created in 2011 with the mission of producing the new generation of leads for neuromodulation for treatment of chronic pain and Parkinson: unbreakable, less invasive and cheaper.
Progress Tech Transfer Fund VC Fund · Luxembourg, Luxembourg, Luxembourg · 3 investments in the past 12 months
Investment fund specialized in sustainable technologies from universities and public research organizations, start-ups, spin-offs, and entrepreneurs.
Show more
Investment focus
  • Biotechnology, Water, Manufacturing
  • Series A, Seed, Funding Round
  • Italy, Ireland, United Kingdom
Portfolio highlights
  • WembraneX — WembraneX's goal is to make wastewater treatment facilities more cost-effective by introducing a new class of anti-fouling and anti-biofouling membranes.
  • Naturbeads — Naturbeads creates biodegradable, sustainable and cost competitive cellulose microbeads to replace currently used microplastics.
  • Valuematic — Valuematic realizza soluzioni per il trattamento e gestione dei dati favorendo il miglioramento nei processi organizzativi e informativi di aziende ed enti.
INGENIUM Emilia Romagna VC Fund
INGENIUM Emilia Romagna was started with EUR 5.30 million by the Emilia Romagna region and EUR 1.7 million from fund managers. Managed by META Investment, the nine-year fund operated through the temporary acquisition of minority stakes in high-opportunity technological companies. It is now fully invested.
Show more
Investment focus
  • Medical, Health Care, Privacy
  • Seed, Angel, Funding Round
  • Italy
Portfolio highlights
  • CellPly — Cellply is a life-science company focused on developing next-generation analytical tools enabling a deep characterization of cancer immunotherapies, cell therapies and cell-based biotherapeutics. The company aims to support the development of novel cancer immunotherapies by accelerating R&D, automating the quality control and advancing theability to monitor the clinical response to these treatments.Through the use of proprietary microfluidic technologies with Co-Culture Array technology, highly-automated analytical instruments and AI-powered image and data analytics, Cellply products define the function of the immune system one cell at a time, combining functional data with other multiplex data and providing unprecedented single-cell analytical solutions.
  • GreenBone Ortho — GreenBone Ortho was founded in Faenzato offer advanced and innovative solutions in the field of orthopaedics and bone regeneration, using the Rattan wood.
  • Angiodroid — Angiodroid srl, a medical technology company, focuses on hemodynamics, vascular surgery, and interventional radiology. It offers an automatic injection system for carbon dioxide angiography. Its products include carbon dioxide injector that is used as a contrast medium for pheriperal interventional angiography; and a single use kit, which iscomposed of French catheters and a custom connection line. The company is based in San Lazzaro di Savena, Italy.
Club degli Investitori VC Fund · Torino, Piemonte, Italy · 5 investments in the past 12 months
Club degli Investitori (Investors Club) is a network of investors and business angels that invest on early-stage SMEs and startups. The community of 300+ Members (entrepreneurs, CEOs, executive managers) actively scouts for investing opportunities on SMEs & startups and invests with a minimum ticket of €200k. The Club supports business byinvesting capital and by leveraging the Members' network and experience.Club degli Investitori is supported by Unicredit and KPMG Italy.
Show more
Investment focus
  • Health Care, E-Commerce, Information Technology
  • Seed, Series A, Series B
  • Italy, Switzerland, United Kingdom
Portfolio highlights
  • Stema — It serves as a platform for hiring engineers
  • Approxima — Approxima medical is developing a novel treatment for patients with tricuspid valve regurgitation
  • Lymphatica Medtech — Lymphatica Medtech is a medical device development company developing a minimally invasive solution for chronic lymphedema.Lymphedema is the chronic swelling that generally occurs in the arms or the legs.Lymphedema is most commonly caused by the removal of or the damage to the lymph nodes as a part of cancer treatment. It results from ablockage in the lymphatic system, which is part of the immune system. The blockage prevents the lymphatic system from draining excess fluids, and the fluid buildup leads to swelling, infections, and pain.Unfortunately, there is no cure for lymphedema. It can be managed with early diagnosis and diligent care of the affected limb, through daily compression, bandages, and manual drainage sessions. From the moment of the diagnosis, the life of lymphedema patients changes forever.Cancer and cancer-related interventions (i.e. surgery, radiotherapy) are frequent causes of lymphedema occurring both in the upper and lower limbs. Breast cancer survivors are at high risk for developing lymphedema, as well as patients treated for melanoma, pelvic and head and neck cancer or other cancer treatments that require lymph node dissection. Physical trauma can also result in lymphedema, a major cause of lymphatic disease among wounded veterans.Lymphedema is associated with significantly impaired quality of life, skin changes, increased risk of infection and in rare cases lymphedema itself may undergo malignant transformation.Lymphatica offers a permanent solution that will allow patients to regain their normal lifestyle.
Claris Ventures VC Fund · Torino, Piemonte, Italy
Claris Ventures is a venture capital firm supporting the best scientists in building successful life sciences companies that will impact people's lives
Show more
Investment focus
  • Biotechnology, Health Care, Therapeutics
  • Seed, Series A, Series B
  • Italy, United Kingdom
Portfolio highlights
  • NeoPhore — NeoPhore targets the dynamics of cancer neoantigen evolution and makes effective medicines that will become a key part of the next-generation of cancer immunotherapies.
  • ALKemist Bio — ALKemist Bio provides cell treatment to cancer patients.
  • Repron Therapeutics — Repron Therapeutics provides treatments for solid tumor cases where radical excision is not possible and metastasis or recurrence is extremely likely.
Eureka Venture VC Fund · Milano, Lombardia, Italy
Eureka! is the first independent Italian venture capital Asset Management company exclusively focused on deep tech investments
Show more
Investment focus
  • Nanotechnology, Renewable Energy, Medical Device
  • Funding Round, Seed, Pre-Seed
  • Italy
Portfolio highlights
  • Planckian — Charging the future by powering energy with science We explore frontiers of energy science by developing quantum...
  • INTA Systems — Nanotech and artificial intelligence for biomolecular analysis
  • BeDimensional — New Material Solution
StartUp Health VC Fund · New York, New York, United States
Organizing and investing in a global army of entrepreneurs committed to achieving health moonshots
Show more
Investment focus
  • Health Care, Wellness, Medical
  • Seed, Funding Round, Pre-Seed
  • United States, Canada, United Kingdom
Portfolio highlights
  • AvoMD — AvoMD is reimagining clinical decision support with interactive point-of-care software, available standalone and via EHR integrations, and seamless content building tools.
  • Pear Suite — Pear Suite empowers community health workers with technology, education, and community, helping them do their best work and serve their communities.
  • Hidoc Consult — Hidoc Consult: Boost your well-being with free consultations, 24/7 access to quality healthcare, complete privacy, user-friendly, and a trusted network of HCPs
European Circular Bioeconomy Fund VC Fund · Bonn, Nordrhein-Westfalen, Germany · 2 investments in the past 12 months
European Circular Bioeconomy Fund invest and partner with entrepreneurs to accelerate late-stage circular bioeconomy companies.
Show more
Investment focus
  • Biotechnology, AgTech, Agriculture
  • Series B, Series A, Series C
  • The Netherlands, France, Italy
Portfolio highlights
  • OroraTech — From safeguarding forests and ecosystems to protecting communities and critical assets, OroraTech's advanced technology and reliable insights address challenges, mitigate risks, and drive meaningful impact.
  • Elicit Plant — We work with farmers around the world to meet the challenges of climate change and the impact of water scarcity on field crops.
  • watttron — Watttron invents a revolutionary heating system that can heat up surfaces heterogeneously.Watttron develops an innovative heating technology that can be used in various industrial processes. It is superior to current heating systems in many ways and offers a number of advantages. On the following pages, you will find information about possibleapplications and opportunities.The company is located in the Technologie- und Gründerzentrum Freital – a technology and start-up center on the outskirts of Dresden, the state capital of Saxony.
Panakes Partners VC Fund · Milano, Lombardia, Italy · 9 investments in the past 12 months
Panakès Partners is a Venture Capital firm, based in Milan, which invests in the most ambitious companies and teams, developing revolutionary technologies and products, in the field of life sciences, aiming to improve the lives of people around the world. Panakès, founded in 2015 by Fabrizio Landi, Alessio Beverina and Diana Saraceni, has 250million under management.
Show more
Investment focus
  • Health Care, Medical, Medical Device
  • Series B, Series A, Seed
  • Italy, Switzerland, United Kingdom
Portfolio highlights
  • Relief — RELIEF s.r.l. aims at introducing on the market miniaturized devices for the treatment of urinary incontinence. In particular, the company proposes a technology that is simple, highly innovative, unisex, effective, low-cost and acceptable from the patient viewpoint.
  • Approxima — Approxima medical is developing a novel treatment for patients with tricuspid valve regurgitation
  • Neuromod Devices — Neuromod is a medical device company formed to advance the science of bi-modal neuromodulation.We are committed to delivering treatments that significantly reduce the suffering of underserved patient populations who live with chronic and debilitating conditions globally. Our goal is to design products that empower patients to take control oftheir own treatment, delivering targeted therapies that integrate seamlessly into a modern lifestyle.Neuromod has developed and patented a bi-modal neuromodulation technology that it is evaluating for neurological disorders including chronic tinnitus, a condition affecting 10% of the adult population and commonly known as 'ringing in the ears'.
3LB Seed Capital Srl VC Fund · Torino, Piemonte, Italy
3LB Seed Capital is not an alternative to start-ups incubators and accelerators, rather acts as a complementary reality that helps to enhance your project in terms of attractiveness for the investor and venture capital market.As investors they are the first willing to know if your project has what it takes to grow successfully. If they areconvinced of your potential, they are ready to bet on you, by joining you and helping you to develop your project.3LB Seed Capital does not provide a percentage of equity in exchange for accompanying activities, but relies exclusively on a premium at the time of its first direct investment in your company.
Show more
Investment focus
  • E-Commerce, Software, Information Technology
  • Seed, Pre-Seed, Series A
  • Italy, United States, United Kingdom
Portfolio highlights
  • YoAgents — Yo Agents nasce dalla unione delle competenze di ogni singolo founder messe a fattor comune per creare un sales hub innovativo.
  • Botsociety — Your conversational design suite. Design and prototype your next chatbot or voice assistant. Create a mockup of your project on Messenger, Slack, Google Assistant, Alexa and more. The next generation design solution for chatbots and voice.
  • Metis Precision Medicine — Metis Precision Medicine is a B-Corp founded with the vision of bringing powerful cancer therapies to patients in need. Metis owns the intellectual property of a suite of anti-Met monoclonal antibodies (mAbs), with different and unique mechanisms of action, and is currently seeking investors, biotech or pharmaceutical companies interested inacquiring the relevant platform technology on a global basis.
Italian Angels for Biotech VC Fund
Angel group focuses on biotech
Show more
Investment focus
  • Health Care, Biotechnology, Pharmaceutical
  • Seed
  • Italy
Portfolio highlights
  • MgShell — MgShell offers intraocular devices for the treatment of age-related macular degeneration and other ocular diseases. Their technology is the only technical solution capable of replicating current clinical practice with a single injection and releasing the same therapeutic drug doses at predetermined periods, autonomously and without surgicalprocedures.
  • CaSRevolution — A novel disease-modifying approach against neurodegeneration
  • Metis Precision Medicine — Metis Precision Medicine is a B-Corp founded with the vision of bringing powerful cancer therapies to patients in need. Metis owns the intellectual property of a suite of anti-Met monoclonal antibodies (mAbs), with different and unique mechanisms of action, and is currently seeking investors, biotech or pharmaceutical companies interested inacquiring the relevant platform technology on a global basis.
Lazio Innova VC Fund · Rome, Lazio, Italy
Lazio Innova is a venture capital firm with its headquarters in Rome in Italy. The firm provides services in areas such as credit support and guarantees, interventions in risk capital, internationalization services, promotion of business networks and services for the creation and enterprise development.
Show more
Investment focus
  • Software, Health Care, Artificial Intelligence
  • Seed, Pre-Seed, Grant
  • Italy, United Kingdom
Portfolio highlights
  • Joinrs — We developed an artificial intelligence model able to read job offers for you and show you the ones that best match your profile.
  • Medicud — Medicud develops a device for treating wounds with negative pressure dressing.
  • Ticketoo — Ticketoo: compra e vendi biglietti fan-to-fan in modo sicuro
Intesa Sanpaolo VC Fund · Torino, Piemonte, Italy · 13 investments in the past 12 months
Intesa Sanpaolo is a banking group that specializes in wealth management, protection, advisory, and digital orientation. Their products and services include accounts, cards, loans, mortgages, insurance, digital payments, retirement planning, investments, and consulting.
Show more
Investment focus
  • Financial Services, FinTech, Renewable Energy
  • Debt Financing, Post-IPO Debt, Series A
  • Italy, United Kingdom, United States
Portfolio highlights
  • La Doria — La Doria is a producer and sells tomato derivatives, ready sauces, preserved legumes, fruit juices, and beverage products. They offer products that include boiled legumes, baked beans, red kidney beans, carrots, ready-made soups and stews, and canned pasta in tomato sauce.
  • MODIFI — Explore digital trade finance and B2B payment solutions that empower your business to grow globally.
  • Aldar Properties — The company has developed some of Abu Dhabi’s most iconic and complex projects, from the Formula 1 facilities on Yas Island to the thriving new Shams Abu Dhabi community on Reem Island. Its property portfolio is diversified and balanced, with residential communities accounting for around half of assets, retail property representing a third, and theremainder split between commercial and hospitality.
UniCredit VC Fund · Milan, Lombardia, Italy · 19 investments in the past 12 months
UniCredit (formerly UniCredito) is an Italian global banking and financial services company. Its network spanning 50 markets in 20 countries, with more than 9,000 branches and over 148,000 employees. Its strategic position in Western and Eastern Europe gives the group one of the region's highest market shares.
Show more
Investment focus
  • Energy, Manufacturing, Financial Services
  • Debt Financing, Post-IPO Debt, Funding Round
  • Italy, Germany, Sweden
Portfolio highlights
  • La Doria — La Doria is a producer and sells tomato derivatives, ready sauces, preserved legumes, fruit juices, and beverage products. They offer products that include boiled legumes, baked beans, red kidney beans, carrots, ready-made soups and stews, and canned pasta in tomato sauce.
  • Unifiber — Unifiber is a broadband service company that focuses on the creation of passive access fiber optic networks.
  • ambrogio transporti — ambrogio transporti is a intermodal transportation company.
Kering Ventures VC Fund · Paris, Ile-de-France, France
Kering Ventures is the venture investment arm of the Kering Group, acquiring minority holdings in startups.
Show more
Investment focus
  • Biotechnology, Interior Design
  • Series A
  • Italy
Portfolio highlights
  • MOGU — By employing one of its finest technologies, mycelium, Mogu delivers responsible products for interior design. Mycelium design with Mogu.
  • SQIM — SQIM is a biotechnological based agency.
3B Future Health Fund VC Fund · Monaco, Bayern, Germany
Helsinn Investment Fund S.A. is a Luxembourg fund focused on early-stage investments in areas of high unmet patient need.
Show more
Investment focus
  • Biotechnology, Therapeutics, Medical
  • Series B, Series A, Funding Round
  • United States, Italy, United Kingdom
Portfolio highlights
  • NeoPhore — NeoPhore targets the dynamics of cancer neoantigen evolution and makes effective medicines that will become a key part of the next-generation of cancer immunotherapies.
  • Fore Biotherapeutics — We are a precision oncology company pioneering the development of cancer therapies guided by our proprietary functional genomics.
  • On Target Laboratories — ON TARGET LABORATORIES discovers and develops fluorescent markers to target and illuminate cancer during surgery so it can be removed more completely.
European Investment Bank VC Fund · Luxembourg, Luxembourg, Luxembourg · 25 investments in the past 12 months
The European Investment Bank (EIB) offers lending, borrowing, and treasury services primarily within the European Union. It provides project loans for public and private sectors, loans to banks and intermediaries, structured finance products, guarantees, and securitization instruments for debts. Additionally, EIB offers equity and fund investmentproducts, including infrastructure and environmental funds, as well as venture capital funds. EIB also supports microfinance and risk-sharing finance for research and innovation and provides technical expertise for sustainable energy projects. Its services include infrastructure advisory, urban development support, guarantees for transport infrastructure, and funding for public-private partnerships and small- to medium-sized enterprises. The bank serves various sectors, including transportation, energy, health, education, and agriculture.
Show more
Investment focus
  • Biotechnology, Health Care, Energy
  • Debt Financing, Post-IPO Debt, Funding Round
  • Germany, France, The Netherlands
Portfolio highlights
  • Amadix — Amadix develops and commercializes breakthrough discoveries in cancer diagnosis with a clear commercial rationale, addressing unmet medical needs in oncology. After analytical validation and demonstration of clinical validity and utility through international multicentre studies, the products will be commercialized worldwide.The most advancedproduct developed by Amadix is Colofast, an innovative non-invasive screening signature for colorectal cancer (CRC) and advanced adenoma diagnosis in blood designed to solve a significant health priority: the high mortality rate due to colon cancer worldwide (around half of the diagnosed patients).Amadix team consist of industry veterans with robust expertise in the Oncology Diagnostic area. They are a top level management team with international experience in cancer diagnostics, the pharmaceutical industry, the biotechnology sector and intellectual property. Amadix also has independent board members with international profiles and many years of experience in oncology and diagnostics, who advise the management team on strategy, commercialization and business development in Europe and the US.
  • Greenlight Biosciences — Next Generation Crop Protection
  • Azienda Comprensoriale Acquedottistica — ACA Spa is an integrated water service company.
Banco BPM VC Fund · Milan, Lombardia, Italy · 2 investments in the past 12 months
Scopri i servizi bancari e finanziari di Banco BPM: conti, mutui, carte, prestiti, assicurazioni, trading e tanto altro. Per privati e imprese.
Show more
Investment focus
  • Manufacturing, Product Design, Energy
  • Debt Financing, Post-IPO Debt, Pre-Seed
  • Italy, United States, Spain
Portfolio highlights
  • Maire Tecnimont — We are enablers of innovation, working alongside businesses to develop sustainable technologies and design integrated solutions that inspire energy transition.
  • Enel Green Power — Enel Green Power is the company that deals with renewable energy from every perspective: from direct sales through PPA, to commitment at the forefront with its plants worldwide.
  • Garofalo Health Care — Garofalo Health Care SpA is a major group in Italy in the authorized private healthcare sector and the only Italian firm listed on the Star division of the Italian Stock Exchange in the healthcare industry.
Spindial Group VC Fund
Spindial Group
Show more
Investment focus
  • Medical, Health Care, Biotechnology
  • Funding Round
  • Italy
Portfolio highlights
  • Glomeria Therapeutics — Glomeria Therapeutics researches, develops, and markets new medical devices for the treatment of serious diseases in the nephrological area. It offers DesmoPD, peritoneal dialysis connection system; SmartPD, an automated management device for peritoneal dialysis solutions to be instilled in peritoneum; and solutions for peritoneal dialysis.Andrea Zanella founded Glomeria Therapeutics in 2010. Its headquarters is in Chieti in Italy.
MVM Life Science Partners VC Fund · London, England, United Kingdom
MVM invests in innovative healthcare companies. Our active portfolio companies are transforming the delivery of healthcare by enabling higher quality, cost-effective care in large, global markets.
Show more
Investment focus
  • Health Care, Biotechnology, Medical
  • Funding Round, Series B, Series C
  • United States, United Kingdom, Switzerland
Portfolio highlights
  • Ossio — OSSIO is an orthopedic fixation company committed to transforming the orthopedic experience for patients, physicians, and payors. Their vision is to provide the first credible replacement to metal implants in the $10B+ orthopedic fixation market (screws, pins, plates) with an Intelligent Bone Regeneration Technology. OSSIOfiber represents abreakthrough material platform for orthopedic and podiatric surgeons who seek a more biologically friendly way to restore patient stability and mobility with nothing permanent left behind.Founded in 2014, OSSIO began as the culmination of years of biomechanical research and a vision for the possibility of better bone healing. The technological basis of OSSIOfiber™ was developed and would lay the groundwork for ushering in a new breakthrough category of non-permanent fixation, “Bio-Integratives” hardware that has both desired strength AND bio-friendliness. Hardware that has the mechanical strength for easy insertion and secure fixation, while enabling the body to regrow bone, incorporating and replacing the implant (without the adverse inflammation and weakness often seen in “bio-resorbables and other “bio-composites”), has remained elusive to the industry until now.
  • Icotec — Icotec develops and produces carbon fiber reinforced plastic implants for spine surgeries and accident treatments.
  • Nalu Medical — Nalu Medical is an early-stage company that develops a range of medical devices. Their vision to modernize and improve the technology in medical devices, thus improving the lives of people.The Nalu neurostimulation system is a battery-free, micro-implantable pulse generator (iPG) currently cleared by the FDA for both Spinal Cord Stimulation (SCS)and Peripheral Nerve Stimulation (PNS) for mitigating chronic pain. The company was founded in 2014 and is based in Carlsbad, California.
United Ventures VC Fund · Milan, Lombardia, Italy · 7 investments in the past 12 months
We are an independent Venture Capitalfirm supporting visionary entrepreneurs toreinvent industries through technology.
Show more
Investment focus
  • Software, FinTech, Information Technology
  • Series A, Seed, Funding Round
  • Italy, United States, United Kingdom
Portfolio highlights
  • xFarm Technologies — The agricultural business is becoming more and more complex due to legal requirements and product certification. On the other hand, technologies evolve and create opportunity. xFarm is a startup that aims at the digitization of agriculture, providing innovative tools that can support farmers and food supply chain's stakeholders in themanagement of their companies. Created by farmers and tailored to the agricultural sector, its main focus is on ease of use, intuitiveness and complete adaptability to agricultural realities. The digital ecosystem includes a free agricultural application, available on both mobile and desktop and integrated with advanced premium modules, a dashboard Analytics dedicated to professionals and a line of IoT sensors selected, optimized and connected by xFarm.
  • Stema — It serves as a platform for hiring engineers
  • Volume — Payment Infrastructure for the Internet
Sparta Capital VC Fund · Toronto, Ontario, Canada
Sparta Capital Ltd. focuses on product development, manufacturing, distribution, sales and service across a range of technologies. The Company's offering includes four different market verticals: transportation, mining, construction and energy (through biomass conversion). These offerings include optimization of energy consumption in thecommercial and manufacturing sectors, construction and energy through biomass conversion, energy conservation in mining, and energy savings in transportation. It is focused on the expansion of a range of divisions, including photoluminescent safety products division, energy audit (EMD) division, biomass division and mining division.
Show more
Investment focus
  • Solar, Life Science, Biotechnology
  • Series A, Series B
  • Italy, Germany
Portfolio highlights
  • Sunvigo — Sunvigo provides you with cheap solar power from your roof and real green power from the grid.
  • GFBiochemicals — GFBiochemicals is the only company to produce levulinic acid derivatives at commercial scale directly from biomass.
Cube Labs VC Fund · Rome, Lazio, Italy
We enable innovation
Show more
Investment focus
  • Wellness, Health Care, Biotechnology
  • Corporate Round
  • Italy
Portfolio highlights
  • Adamas Biotech — More than a decade of basic research in the field of botanical function-specific antioxidants. The nutraceutical solutions proposed to stem from a patented protected technology.
Embed Capital VC Fund · Milan, Lombardia, Italy
Embed Capital directly invests in startups, established or in the process of creation.Embed is mainly focused on innovative companies that:- Are active in the so-called “real economy” sectors: industrials, technology, environment, services, retail or social;- Are characterized by simple and intuitive business models and valuepropositions, and operate in markets or market segments featuring high growth potential;- Present a clear competitive advantage and high barriers-to-entry;- Are cash-generative in the medium term.Given that Embed Capital is not a closed-end fund, it doesn’t have specific time-constrains and it can assess on a project-by-project basis to determine the best time to sell a participation, and sign customized agreements with the entrepreneurs.
Show more
Investment focus
  • Information Technology, Health Care, Mobile
  • Seed, Funding Round, Pre-Seed
  • Italy, Switzerland, United Kingdom
Portfolio highlights
  • Piantando — Piantando sells plants connected to initiatives for the preservation of the planet engaged in the following areas: land, water, climate, biodiversity and local communities. Each plant is equivalent to a transparent and unique contribution, destined to an initiative certified by our Value Chain. Everyone become ambassadors of a new way of livinggreen and understanding their commitment to the planet.
  • FrescoFrigo - Healthy food close to you — FrescoFRIGO is a smart fridge with fresh and quality products designed for the needs of worker. Improve everyday lifestyle, through automated proximity selling of good, fresh and healthy product, innovating technology and user experience.
  • The Nemesis — The Nemesis is the playground for play-to-earn games and adventures in virtual worlds. Accessible on both mobile and desktop.
Padda Health VC Fund · Milan, Lombardia, Italy
Siamo partner di private equity con una struttura family office. Selezioniamo start-up tech-driven con idee innovative e voglia di emergere.
Show more
Investment focus
  • Medical, Health Care, Biotechnology
  • Seed
  • Italy
Portfolio highlights
  • GenomeUp — GenomeUp is an AI platform (SaaS) to enabling doctors and clinical institutions to diagnose and treat rare genetic diseases in less than 24h. GenomeUp is involved in international research projects and clinical trials in partnership with universities and research centers.
  • TeiaCare — TeiaCare is an Italian start-up born in 2018 with the aim of transferring technology and innovation knowledge to care homes.Our first solution, Ancelia, is an AI-powered operating system designed to increase transparency in the care and assistance processes, both inside the care home and towards residents' families.TeiaCare, based inMilan, operates in Italy and Spain, has a team of 15 people and is supported by international investors.
  • VoiceMed — Track respiratory health using voiceWe bring deep-tech innovation into your smartphone. With vocal biomarkers and artificial intelligence, we track the evolution of respiratory diseases.
Longwood Fund VC Fund · Boston, Massachusetts, United States · 6 investments in the past 12 months
Longwood creates and invests in science-based companies that develop novel solutions for important medical problems
Show more
Investment focus
  • Biotechnology, Therapeutics, Health Care
  • Series A, Series B, Series C
  • United States, United Kingdom, Italy
Portfolio highlights
  • Evommune — Evommune is taking a tissue-based approach to advance insights and accelerate the development of transformative medicines in inflammatory diseases.
  • Be Biopharma — Be Bio is developing a proprietary class of engineered B cells as medicines that unleash the potential of cell therapies in applications beyond cytotoxicity.
  • Newleos Therapeutics — Newleos Therapeutics is a biotech startup dedicated to producing safer and more effective neuroscience medicines.
Forbion Capital Partners VC Fund · Naarden, Noord-Holland, The Netherlands · 18 investments in the past 12 months
Impacting the future of medicine.
Show more
Investment focus
  • Biotechnology, Health Care, Medical
  • Series B, Series A, Series C
  • United States, United Kingdom, The Netherlands
Portfolio highlights
  • Numab — Numab Therapeutics AG
  • Verdiva Bio — Verdiva Bio is committed to developing next-generation therapies to help people living with obesity, cardiometabolic disorders, and related complications achieve better outcomes via more patient-friendly therapeutic options.
  • Orbis Medicines — Orbis Medicines is a novel macrocyclic chemistry and computational platform for high-throughput drug discovery.
FITEC VC Fund · Milan, Lombardia, Italy
FITEC, managed by Fondo Italiano d’Investimento SGR, with a target commitment of Euro 150 million is the first Italian technology private equity and late-stage venture capital fund. It is entirely dedicated to equity investments in small and medium-sized technology-based Italian companies, which are either backed by VC funds, like Termo, Everli andBeMyEye, or have been self-financed and are owned by entrepreneurs seeking further investment to grow, like Seco and Healthware Group. The fund announced its first closing in September 2017 with Cassa Depositi e Prestiti as Cornerstone Investor. Fondo Italiano d’investimento SGR currently manages a total of eight investment funds, dedicated to institutional investors, for a total of about Euro 3 billion of target Asset Under Management.
Show more
Investment focus
  • Information Technology, Software, Mobile
  • Series B, Series C, Private Equity
  • Italy, United Kingdom
Portfolio highlights
  • Intrauma — Intrauma was founded in 2006 and is based in Rivoli, near Turin, in Piedmont. The company designs and manufactures the O’nil range of locking plates, which has been in clinical use since 1998. Intrauma is committed to on-going research and development of both materials and manufacturing processes, in collaboration with experienced trauma surgeons,to provide the highest quality implants and to simplify today’s approach to Traumatology. Intrauma is also dedicated to building and maintaining strong customer relationships, believing that this is the foundation of a successful business.Intrauma TODAYToday, Intrauma is the second largest supplier of trauma devices in Italy, and is rapidly expanding its international sales and marketing operations across the world.This also gives the company the opportunity to work with surgeons across the globe, developing more unique products and continuing to improve traumatology techniques for the benefit of both patient and surgeon.
  • Apparound — How to digitize the corporate sales journey? With Apparound, the all-in-one solution to a successful digital selling.
  • UNGUESS (formerly AppQuality) — UNGUESS is the crowdsourcing platform for effective testing and real insights. Take the guesswork out of your work.
Crédit Agricole Italia VC Fund · Parma, Emilia-Romagna, Italy · 2 investments in the past 12 months
Crédit Agricole Italia is a bank that offers loans and financial services.
Show more
Investment focus
  • Financial Services, Finance, Water
  • Debt Financing, Seed
  • Italy
Portfolio highlights
  • Krill Design — Krill Design is a design studio that creates circular economy projects to convert organic waste into material resources. It is a patented process that intercepts resources from the food supply chain to create zero-impact eco-designed 3D printed products.
  • Italcer Group — Italcer Group is a manufacturer of indoor and outdoor ceramic products.
  • Clessidra — Clessidra Private Equity is an investment firm that invests in the Italian upper-middle markets. Clessidra Private Equity was founded in 2003 and was headquartered in Milan, Italy.
Estor VC Fund
Estor is a Investment Firm.
Show more
Investment focus
  • Health Care, Biotechnology, Medical Device
  • Seed
  • Italy
Portfolio highlights
  • Endostart — Endostart development and manufacturing of a new generation medical devices for gastrointestinal endoscopy.
Angels4Women VC Fund · Milan, Lombardia, Italy
Angels4Women is a company that invests in business startups lead by females.
Show more
Investment focus
  • Retail, Fashion, Lingerie
  • Seed, Angel, Funding Round
  • Italy, United States
Portfolio highlights
  • Diamante — Diamante is a company that develops and manufactures autoimmune disease diagnosis devices using nanomaterials. It exploits plants as bioreactors for the sustainable production of nanoparticles based on modified plant viruses that are used in developing new tools. Diamante was founded in 2016 and is headquartered in Verona, Italy.
  • FUTURELY — FUTURELY is a platform which will help to choose university.
  • Chite Milano — Lingerie the Italian way. Discover 100% Made in Italy lingerie. Make your own: customise your lingerie and nightwear.
Schia Ventures VC Fund
Schia Ventures is investment firm.
Show more
Investment focus
  • Medical, Health Care, Biotechnology
  • Funding Round
  • Italy
Portfolio highlights
  • CellPly — Cellply is a life-science company focused on developing next-generation analytical tools enabling a deep characterization of cancer immunotherapies, cell therapies and cell-based biotherapeutics. The company aims to support the development of novel cancer immunotherapies by accelerating R&D, automating the quality control and advancing theability to monitor the clinical response to these treatments.Through the use of proprietary microfluidic technologies with Co-Culture Array technology, highly-automated analytical instruments and AI-powered image and data analytics, Cellply products define the function of the immune system one cell at a time, combining functional data with other multiplex data and providing unprecedented single-cell analytical solutions.
Scientifica Venture Capital VC Fund · Roma, Lazio, Italy · 2 investments in the past 12 months
Scientifica Venture Capital offers private equity and venture capital investment services for Italy based startups and firms.
Show more
Investment focus
  • Medical, Biotechnology, Manufacturing
  • Seed, Private Equity
  • Italy
Portfolio highlights
  • Relicta — Relicta solution is a water-soluble bioplastic material obtained from fish processing waste and suitable for packaging solutions.
  • OhmSpace — OhmSpace provides the satellite market with reliable resistojets.
  • QuantaBrain — QuantaBrain purpose is to accelerate the diagnosis of psychiatric and neurodevelopmental diseases by applying artificial intelligence.
Launch Tennessee VC Fund · Nashville, Tennessee, United States
Launch Tennessee provides startup resources to entrepreneurs, including capital sources, mentorship, accelerators, entrepreneurship training and more
Show more
Investment focus
  • Software, Health Care, Medical
  • Grant, Seed, Series A
  • United States, China, Italy
Portfolio highlights
  • DAXOR — DAXOR Corporation is an innovative medical instrumentation and biotechnology company. DAXOR designed and developed the BVA-100 Blood Volume Analyzer. It is the first instrument approved by the FDA to provide rapid direct measurement of a patient's true blood volume. We believe that the BVA-100 Blood Volume Analyzer has the potential totransform therapy in a broad range of surgical and medical conditions. It is our goal, working in conjunction with hospitals and clinics, to achieve that possibility.The BVA-100 is a semi-automated Blood Volume Analyzer. It is used in conjunction with a single use diagnostic kit. It is the first FDA-approved instrument to provide rapid direct measurement of a patient's blood volume.
  • Preteckt — Preteckt's AI software predicts & prevents breakdowns in buses & coaches. Reduce costs, maximize uptime, & extend vehicle life
  • Daily Crunch — Daily Crunch is an offline and online store that offers cherry-berry nuts, cacao sea salt, and sprouted almonds products.
Lumen Ventures VC Fund · London, England, United Kingdom
PortfolioTeam London | City Road 152-160, EC1V 2NX Roma | Via Giovanni Battista Morgagni, 3, 00161
Show more
Investment focus
  • B2B, E-Commerce, Food and Beverage
  • Seed, Pre-Seed, Series A
  • Italy
Portfolio highlights
  • Macai — Macai offers thousands of high-quality products delivered at your doorstep in a few minutes.Macai is the first Italian company active in the Q-commerce space. Founded by Giovanni Cavallo, serial entrepreneur with a deep background in food delivery, the project is now live in Milan and Turin. Compared to other players in the industry, Macai ismore focused on providing a wider offer than on the speed variable. We aim at building an online full grocer, with more than 7000 skus delivered in less than 45 minutes.
  • GenomeUp — GenomeUp is an AI platform (SaaS) to enabling doctors and clinical institutions to diagnose and treat rare genetic diseases in less than 24h. GenomeUp is involved in international research projects and clinical trials in partnership with universities and research centers.
  • Insoore — Insoore is a platform that helps insurance companies to improve the claims management process, thanks to on-demand photographic inspections and damage estimates provided by a community of experts.
AbbVie Biotech Ventures VC Fund · North Chicago, Illinois, United States
AbbVie is a global, research-based biopharmaceutical company formed in 2013 following separation from Abbott Laboratories. The company's mission is to use its expertise, dedicated people and unique approach to innovation to develop and market advanced therapies that address some of the world's most complex and serious diseases. Togetherwith its wholly-owned subsidiary, Pharmacyclics, AbbVie employs ~29,000 people worldwide and markets medicines in more than 175 countries.
Show more
Investment focus
  • Biotechnology, Health Care, Therapeutics
  • Series A, Series B, Series C
  • United States, China, Italy
Portfolio highlights
  • Nitrase Therapeutics — Nitrase Therapeutics is a platform company developing drugs against a newly identified class of enzymes called Nitrases, initially targeting Parkinson’s disease. The therapies that Nitrome is developing will target these enzymes and potentially help slow or halt the progression of diseases such as Parkinson’s. While the initial focus is onParkinson's disease, the company aims to expand its proprietary platform to include other disease indications.
  • Quanta Therapeutics — Quanta is a biotechnology company uncovering novel cancer therapeutic candidates using allosteric modulation to target driver oncogenes. The company was founded in 2018 and is based in San Francisco, CA.
  • AmbAgon Therapeutics — AmbAgon Therapeutics is a developer of cancer molecule therapeutics. The company offers research of a small molecule that augments a tumor-suppressing protein. AmbAgon Therapeutics was founded by Christian Ottmann, Lucas Brunsveld, and Michelle Arkin.
Finalca VC Fund · Bologna, Emilia-Romagna, Italy
Finalca is an Investment Company.
Show more
Investment focus
  • Medical, Health Care, Biotechnology
  • Seed
  • Italy
Portfolio highlights
  • GenomeUp — GenomeUp is an AI platform (SaaS) to enabling doctors and clinical institutions to diagnose and treat rare genetic diseases in less than 24h. GenomeUp is involved in international research projects and clinical trials in partnership with universities and research centers.
Angelini Ventures VC Fund · Rome, Lazio, Italy · 4 investments in the past 12 months
Angelini Ventures is an investment firm.
Show more
Investment focus
  • Health Care, Therapeutics, Biotechnology
  • Series A, Series C, Seed
  • United States, Italy, Belgium
Portfolio highlights
  • Nobi — Fall detection for the elderly at your home or in a residential care center with the smart Nobi lamp. Nobi ensures that you can be helped quickly.
  • Aptadir Therapeutics — Reprogramming DNA methylation in disease conditions by RNA therapeutics APTADIR Contact us NEWS Press Release Reprogramming DNA methylation by RNA therapeutics A novel therapeutic approach for untreatable cancers and rare diseases Aberrant methylation by DNA methyltransferase 1 (DNMT1) of certain genes may cause abnormal cell development and lead to disease. Current therapies targeted to inhibit
  • Neumirna Therapeutics — Founded in 2020, NEUmiRNA focuses on achieving transformative disease modification for neurological conditions.
a|impact VC Fund
a|impact invests in the prevailing form of equity or quasi-equity, focusing our operations mainly on companies.
Show more
Investment focus
  • Medical, Health Care, Biotechnology
  • Seed
  • Italy
Portfolio highlights
  • GenomeUp — GenomeUp is an AI platform (SaaS) to enabling doctors and clinical institutions to diagnose and treat rare genetic diseases in less than 24h. GenomeUp is involved in international research projects and clinical trials in partnership with universities and research centers.
Investors by industry
Investors by country
VC (Venture Capital) Funds in Italy by industry